In Chicagos high-pressure professional environment, this becomes particularly problematic
Wu, J.H., Hodgson, J.M., Ward, N.C., Clarke, M.W., Puddey, I.B., Croft, K.D., 2005
The FLOW trial demonstrated a 24% reduction in kidney disease progression in patients with type 2 diabetes and chronic kidney disease taking semaglutide
Bech EM, Martos-Maldonado MC, Wismann P, et al
T., Moon, M
Bioassay-guided isolation of proanthocyanidins with antioxidant activity from peanut ( Arachis hypogaea ) skin by combination of chromatography techniques